Records containing: Lung Cancer Stage IV
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-25Quality and Safety of Screening for Brain Metastases by Gadopiclenol in Patients With Cancer at High Risk of Developing Brain Metastases
-
CLINICAL_TRIALS study record update · 2025-12-18An Open-Label, Phase 1b/2a Study of SLC-391, an AXL Inhibitor, in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
-
CLINICAL_TRIALS study record update · 2025-12-18A Phase II, Multi-Cohort Trial of Combination Nivolumab and Temozolomide in Recurrent/Refractory Small-Cell Lung Cancer and Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-09-02Demographic, Clinical, Histological and Molecular Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohort, an Observational Cohort Study: Lung Cancer ID Study
-
CLINICAL_TRIALS study record update · 2025-03-28Clinical Efficacy and Complications of Small-bore Versus Ultra-small Bore Chest Drain in Malignant Pleural Effusion: a Randomized Clinical Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-09Observational Study of Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System
-
CLINICAL_TRIALS study record update · 2024-09-19Re-induction of a Systemic Immune Response After Initial Response With Immune Therapy With Single-dose Radiotherapy in Metastatic or Locally Recurrent Lung Cancer: A Prospective Phase II Trial (Re-Induce 2)
-
CLINICAL_TRIALS study record update · 2024-08-09Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab.
-
CLINICAL_TRIALS study record update · 2024-03-20Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung Tumors Using Real-Time Tumor Tracking & Respiratory Gating: A Seamless Phase I/II Prospective Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-02-02Resilience Measurement, Prediction, and Its Role in Older Adults With Late-Stage Lung Cancer
-
CLINICAL_TRIALS study record update · 2023-11-09Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
-
CLINICAL_TRIALS study record update · 2023-09-29Stepped and Early Psychosocial Care in Advanced Lung Cancer Through E-health
-
CLINICAL_TRIALS study record update · 2023-08-21The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2023-03-20Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs: A Multicenter, Open Label, Phase II Clinical Study
-
CLINICAL_TRIALS study record update · 2023-01-27A Phase II Study for the Evaluation of the Feasibility of Lazertinib 160mg Per Day in Patients With EGFR T790M Mutant Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2022-08-03Self-System Therapy for Older Adults With Advanced Lung Cancer (SST-LC)
-
CLINICAL_TRIALS study record update · 2022-05-17Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Cancer Panel
-
CLINICAL_TRIALS study record update · 2022-02-08A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
-
CLINICAL_TRIALS study record update · 2022-01-21A Retrospective Study of Clinical Outcomes and Liver-related Toxicity of Patients With Lung Cancer Treated With Immune-checkpoint Inhibitors
-
CLINICAL_TRIALS study record update · 2021-03-15A Phase III, Randomized,Double-Blind, Multi-center Study to Investigate the Efficacy and Safety of SHR-1210 in Combination With Carboplatin and Paclitaxel Versus Placebo in Combination With Carboplatin and Paclitaxel in First-Line Stage IV Squamous Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2020-09-24Personalizing Immune Checkpoint Inhibitor Therapy for Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-08-29Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients - a Pilot Study
-
CLINICAL_TRIALS study record update · 2017-05-16Icotinib Combined With Stereotactic Body Radiation Therapy (SBRT) for Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Sensitive Mutation